Telix, Regeneron (REGN), and NAYA Therapeutics are turning radiopharmaceuticals into one of Wall Street’s more serious new growth stories—while quietly building the kind of supply-chain moats that would make an oil baron blush.
Telix and Regeneron: A $2 Billion Bet on “Hot”…